Skip to main content
Log in

Antagonism of reserpine rigidity without inducing sedation

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The effects of pretreatment with chloropromazine, promethazine or SKF 7265 on the severity of reserpine-induced rigidity were evaluated using a series of behavioral responses. Chlorpromazine (10 mg/kg) reduced the severity of the syndrome, particularly the tremor, but only at doses that also produced marked sedation. SKF 7265 was more effective than chlorpromazine and produced no detectable sedation or other motor impairment. Promethazine was ineffective in protecting against the effects of reserpine. These studies demonstrate that motor and behavioral abnormalities induced by high doses of reserpine can be blocked without inducing generalized sedation. This would suggest that it is possible to separate pharmacologically the motor pathways responsible for reserpine rigidity and those responsible for sedation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Anderson RJ, Brigham P, Southwick S (1979) The antispasticity efficacy and receptor selectivity of 10-(2-dimethylaminoethyl) acridan. Pharmacologist 21:149

    Google Scholar 

  • Carlsson A (1978) Mechanism of action of neuroleptic drugs. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven Press, New York, pp 1057–1070

    Google Scholar 

  • Glick SD, Goldfarb J (1976) Behavioral pharmacology. CV Mosby, St. Louis, pp 342–343

    Google Scholar 

  • Johnels B, Steg G (1978) The role of the corpus striatum in reserpine-induced rigidity and akinesia in the rat. Acta Neurol Scand 57 (Suppl. 67):225

    Google Scholar 

  • Jurna I, Lanzer G (1969) Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity. Naunyn-Schmiedeberg's Arch Pharmacol 262:309–324

    Google Scholar 

  • Maxwell DR, Read MA, Sumpter EA (1974) Pharmacology of M and B 18,706, a drug which selectively reduces decerebrate rigidity. Br J Pharmac 50:35–45

    Google Scholar 

  • Morrison AB, Webster RA (1973a) Drug-induced experimental Parkinsonism. Neuropharmacology 12:715–724

    Google Scholar 

  • Morrison AB, Webster RA (1973b) Reserpine rigidity and adrenergic neurones. Neuropharmacology 12:725–733

    Google Scholar 

  • Steg G (1964) Efferent muscle innervation and rigidity. Acta Physiol Scand 62 (Suppl 225):1–53

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Southwick, S., Anderson, R.J. Antagonism of reserpine rigidity without inducing sedation. Psychopharmacology 74, 29–32 (1981). https://doi.org/10.1007/BF00431752

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00431752

Key words

Navigation